Health CareHealth Care Equipment & Services
  • Price (USD)127.84
  • Today's Change-0.89 / -0.69%
  • Shares traded1.00
  • 1 Year change+21.98%
  • Beta0.8178
Data delayed at least 15 minutes, as of Sep 21 2021 21:10 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

  • Revenue in USD (TTM)31.60bn
  • Net income in USD3.88bn
  • Incorporated2014
  • Employees90.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MDT:NYQ since
Intersect ENT IncAnnounced06 Aug 202106 Aug 2021Announced-0.14%991.75m
Avenu Medical IncAnnounced30 Sep 202030 Sep 2020Announced24.49%--
Data delayed at least 15 minutes, as of Sep 21 2021 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Stryker Corporation16.25bn2.08bn101.16bn43.00k49.107.3233.486.235.465.4642.6036.650.49851.716.61377,814.006.397.327.378.7263.8765.6912.8213.781.32--0.479739.73-3.587.61-23.242.1312.5216.25
Intuitive Surgical, Inc.5.16bn1.62bn120.66bn8.08k75.7711.1161.7623.3713.3813.3842.6191.300.4612.668.54638,893.7014.6313.9916.0615.5968.6968.8431.7428.805.42--0.000.00-2.6812.82-23.1112.4933.35--
Medtronic PLC31.60bn3.88bn172.05bn90.00k44.593.3426.025.452.872.8723.3638.290.34032.366.13351,077.804.214.774.755.3666.9568.5112.3714.962.3415.470.334560.934.160.8752-25.94-0.21575.318.83
Abbott Laboratories40.23bn6.40bn221.83bn109.00k35.026.5622.455.513.573.5622.4719.070.56653.347.15369,
Thermo Fisher Scientific Inc.38.25bn8.60bn234.89bn80.00k27.636.3721.256.1421.6121.6196.1793.680.59174.506.68478,125.0013.306.4614.787.3151.2946.1522.4714.502.1121.210.33757.9826.1413.6972.1126.3428.377.21
Data as of Sep 21 2021. Currency figures normalised to Medtronic PLC's reporting currency: US Dollar USD

Institutional shareholders

30.76%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 2021106.24m7.90%
BlackRock Fund Advisorsas of 30 Jun 202164.75m4.81%
SSgA Funds Management, Inc.as of 30 Jun 202155.85m4.15%
Massachusetts Financial Services Co.as of 30 Jun 202146.11m3.43%
Wellington Management Co. LLPas of 30 Jun 202133.45m2.49%
Lazard Asset Management LLCas of 30 Jun 202124.60m1.83%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 202122.69m1.69%
Geode Capital Management LLCas of 30 Jun 202121.81m1.62%
JPMorgan Investment Management, Inc.as of 30 Jun 202119.88m1.48%
Capital Research & Management Co. (Global Investors)as of 30 Jun 202118.54m1.38%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.